OPIANT PHARMACEUTICALS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2011 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2011 to Q1 2022.
  • Opiant Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2022 was $800K, a 300% increase year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $200K.
  • Opiant Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2017 was $981K, a 90.4% decline from 2016.
  • Opiant Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2016 was $10.2M, a 913% increase from 2015.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $800K +$600K +300% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q1 2021 $200K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2017 $0 -$132K -100% Sep 11, 2017 10-Q 2017-12-04
Q3 2016 $132K Aug 1, 2016 Oct 31, 2016 10-Q 2016-12-15
Q3 2014 $7.38M $174K -$906K -83.9% Aug 1, 2014 Oct 31, 2014 10-Q 2014-12-09
Q2 2014 $8.28M $1.54M May 1, 2014 Jul 31, 2014 10-K 2015-10-26
Q1 2014 $0 Feb 1, 2014 Apr 30, 2014 10-Q 2014-06-10
Q4 2013 $5.66M $0 0% Nov 1, 2013 Jan 31, 2014 10-Q 2014-03-17
Q3 2013 $1.08M +$1.05M +3875% Aug 1, 2013 Oct 31, 2013 10-Q 2013-12-16
Q4 2012 $5.66M Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 $27.2K -$504K -94.9% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-16
Q3 2011 $531K Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.